EDAP TMS reported EUR9.67M in Cost of Sales for its fiscal quarter ending in March of 2026.





Cost Of Sales Change Date
AngioDynamics USD 37.29M 786K Sep/2025
Boston Scientific USD 1.86B 29M Jun/2026
EDAP TMS EUR 9.67M 1.76M Mar/2026
Henry Schein USD 2.43B 129M Jun/2026
Medtronic USD 3.8B 195M Mar/2026
Veracyte USD 42.19M 3.7M Jun/2026